Avoro Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $171M | Buy |
|
|||||
|
2024
Q4 | $311M | Hold |
|
|||||
|
2024
Q3 | $319M | Sell |
|
|||||
|
2024
Q2 | $474M | Sell |
|
|||||
|
2024
Q1 | $562M | Hold |
|
|||||
|
2023
Q4 | $419M | Buy |
|
|||||
|
2023
Q3 | $488M | Sell |
|
|||||
|
2023
Q2 | $530M | Buy |
|
|||||
|
2023
Q1 | $503M | Buy |
|
|||||
|
2022
Q4 | $411M | Hold |
|
|||||
|
2022
Q3 | $351M | Sell |
|
|||||
|
2022
Q2 | $254M | Buy |
|
|||||
|
2022
Q1 | $245M | Buy |
|
|||||
|
2021
Q4 | $281M | Buy |
|
|||||
|
2021
Q3 | $231M | Buy |
|
|||||
|
2021
Q2 | $187M | Buy |
|
|||||
|
2021
Q1 | $160M | Buy |
|
|||||
|
2020
Q4 | $298M | Buy |
|
|||||
|
2020
Q3 | $235M | Hold |
|
|||||
|
2020
Q2 | $269M | Buy |
|
|||||
|
2020
Q1 | $155M | Sell |
|
|||||
|
2019
Q4 | $227M | Buy |
|
|||||
|
2019
Q3 | $126M | Buy |
|
|||||
|
2019
Q2 | $213M | Buy |
|
|||||
|
2019
Q1 | $142M | Sell |
|
|||||
|
2018
Q4 | $139M | Buy |
|
|||||
|
2018
Q3 | $152M | Sell |
|
|||||
|
2018
Q2 | $127M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $27.7M | Sell |
|
|||||
|
2016
Q3 | $84.1M | Sell |
|
|||||
|
2016
Q2 | $26.9M | Buy |
|
|||||
|
2016
Q1 | $22.5M | Buy |
|
|||||
|
2015
Q4 | $19.4M | Buy |
|
|||||
|
2015
Q3 | $15.1M | Buy |
|